ADVANZ PHARMA Corp. commented on the issuance by the UK Competition and Markets Authority of a Statement of Objections to various parties, including ADVANZ PHARMA, related to competition matters pertaining to the Company’s medicines, nitrofurantoin capsules 50mg and 100mg.
July 25, 2019
· 5 min read